Collectively, these findings indicate that araliadiol attenuates AP-1 activation and suppresses MMP-1 and MMP-3 expression in senescent dermal fibroblasts, thereby potentially protecting against ECM degradation and skin aging. Here, JUN is linked to neoplasm.